Azafaros Banks Over €130m To Advance Nizubaglustat Into Phase III

 
• By Kevin Grogan
  
Bornrif, a lighthouse on the Dutch island of Ameland on the edge of the North Sea. Azafaros claims to be a beacon for patients living with severe rare genetic diseases (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Rare Diseases